Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Sequencing of mitochondrial genome of Leptomonas pyrrhocoris H10

PROVIDER: PRJNA598933 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10828080_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 1 of 1

Similar Datasets

Leptomonas pyrrhocoris strain:H10

Project description:Leptomonas pyrrhocoris strain:H10 Genome sequencing

| PRJNA183120 | ENA

Leptomonas pyrrhocoris strain:H10

Project description:Leptomonas pyrrhocoris strain:H10 Genome sequencing and assembly

| PRJNA284491 | ENA

Project description:Study of RNA editing in Leptomonas pyrrhocoris mitochondrion

| PRJNA392757 | ENA

Proteome of standard WHO L. donovani DD8 strain and Leptomonas clinical isolates from India

Project description:Leishmania donovani WHO reference strain MHOM/IN/80/DD8 and Leptomonas seymouri isolates Ld 2001 and Ld39 were used for proteome analysis which were originally isolated from clinical cases of kala azar patients with different inherent antimonial sensitivities. Ld 2001 was Sb-S and Ld 39 was Sb-R. The genome sequencing of these isolates had confirmed co-infection with Leptomonas.

2016-03-16 | MSV000079588 | MassIVE

De novo Epstein-Barr virus infection of pseudostratified nasopharynx epithelial cells differentiated at the air-liquid interface (ALI)

Project description:This donor NP-H10 was susceptible to EBV infection and produced a lytic infection as determined by Zebra and gp350 immunostaining.

2021-04-06 | GSE157243 | GEO

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Leptomonas seymouri BHU1095

Project description:Leptomonas seymouri BHU1095 Genome sequencing and assembly

| PRJNA176882 | ENA

Lactobacillus helveticus H10

Project description:Lactobacillus helveticus H10 Genome sequencing

| PRJNA49153 | ENA

Leptomonas seymouri

Project description:Leptomonas seymouri overview

| PRJNA315328 | ENA

E-GEOD-18068

Project description:Genome-wide transcriptome sequencing at different stages of Drosophila melanogaster development, RNA-seq